OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES
For today there are convincing evidences of beneficial effect of ω-3 polyunsaturated fatty acids (PUFA) - eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids – in a number of cardiovascular diseases. Efficacy of ω-3 PUFA was confirmed by results of the large-scale clinical trials. Data on ω-3 PUF...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2015-12-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/422 |
_version_ | 1797232421062574080 |
---|---|
author | A. V. Govorin A. P. Filev |
author_facet | A. V. Govorin A. P. Filev |
author_sort | A. V. Govorin |
collection | DOAJ |
description | For today there are convincing evidences of beneficial effect of ω-3 polyunsaturated fatty acids (PUFA) - eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids – in a number of cardiovascular diseases. Efficacy of ω-3 PUFA was confirmed by results of the large-scale clinical trials. Data on ω-3 PUFA efficacy in heart failure and cardiac arrhythmia were received, besides their well-known hypolipidemic effect. Low level of ω-3 PUFA biomarker , ω-3 index (content of EPA and DHA in erythrocytes), is considered as a risk factor of coronary heart disease as well as a risk factor of fatal arrhythmias. Use of standardized medicinal product with high content of EPA and DHA leads to the positive therapeutic effect in patients with different cardiovascular diseases. |
first_indexed | 2024-03-08T14:05:32Z |
format | Article |
id | doaj.art-f79c896ff280416c8555878705e52a13 |
institution | Directory Open Access Journal |
issn | 1819-6446 2225-3653 |
language | English |
last_indexed | 2024-04-24T16:00:00Z |
publishDate | 2015-12-01 |
publisher | Столичная издательская компания |
record_format | Article |
series | Рациональная фармакотерапия в кардиологии |
spelling | doaj.art-f79c896ff280416c8555878705e52a132024-04-01T07:43:25ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-12-01819510210.20996/1819-6446-2012-8-1-95-102422OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASESA. V. Govorin0A. P. Filev1Chita Medical AcademyChita Medical AcademyFor today there are convincing evidences of beneficial effect of ω-3 polyunsaturated fatty acids (PUFA) - eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids – in a number of cardiovascular diseases. Efficacy of ω-3 PUFA was confirmed by results of the large-scale clinical trials. Data on ω-3 PUFA efficacy in heart failure and cardiac arrhythmia were received, besides their well-known hypolipidemic effect. Low level of ω-3 PUFA biomarker , ω-3 index (content of EPA and DHA in erythrocytes), is considered as a risk factor of coronary heart disease as well as a risk factor of fatal arrhythmias. Use of standardized medicinal product with high content of EPA and DHA leads to the positive therapeutic effect in patients with different cardiovascular diseases.https://www.rpcardio.online/jour/article/view/422ω-3 polyunsaturated fatty acidsheart failurearrhythmia |
spellingShingle | A. V. Govorin A. P. Filev OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES Рациональная фармакотерапия в кардиологии ω-3 polyunsaturated fatty acids heart failure arrhythmia |
title | OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES |
title_full | OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES |
title_fullStr | OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES |
title_full_unstemmed | OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES |
title_short | OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES |
title_sort | omega 3 polyunsaturated fatty acids in the treatment of patients with cardiovascular diseases |
topic | ω-3 polyunsaturated fatty acids heart failure arrhythmia |
url | https://www.rpcardio.online/jour/article/view/422 |
work_keys_str_mv | AT avgovorin omega3polyunsaturatedfattyacidsinthetreatmentofpatientswithcardiovasculardiseases AT apfilev omega3polyunsaturatedfattyacidsinthetreatmentofpatientswithcardiovasculardiseases |